Corrigendum to “Pharmacokinetics and efficacy of PT302, a sustained-release Exenatide formulation, in a murine model of mild traumatic brain injury” [Neurobiology of Disease Volume 124 (2019) 439–453 /YNBDI_4338]

• Miaad Bader,
• Yazhou Li,
• Daniela Lecca,
• Vardit Rubovitch,
• David Tweedie,
• Elliot Glotfelty,
• Lital Rachmany,
• Hee Kyung Kim,
• Ho-Il Choi,
• Barry J. Hoffer,
• Chaim G. Pick,
• Nigel H. Greig,
• Dong Seok Kim

Affiliations

Miaad Bader

Department of Anatomy and Anthropology, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv 69978, Israel

Yazhou Li

Drug Design and Development Section, Translational Gerontology Branch, Intramural Research Program, National Institutes of Health, National Institute on Aging, Baltimore, MD, USA

Daniela Lecca

Drug Design and Development Section, Translational Gerontology Branch, Intramural Research Program, National Institutes of Health, National Institute on Aging, Baltimore, MD, USA

Vardit Rubovitch

Department of Anatomy and Anthropology, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv 69978, Israel

David Tweedie

Drug Design and Development Section, Translational Gerontology Branch, Intramural Research Program, National Institutes of Health, National Institute on Aging, Baltimore, MD, USA

Elliot Glotfelty

Drug Design and Development Section, Translational Gerontology Branch, Intramural Research Program, National Institutes of Health, National Institute on Aging, Baltimore, MD, USA; Department of Neuroscience, Karolinska Institute, Stockholm, Sweden

Lital Rachmany

Department of Anatomy and Anthropology, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv 69978, Israel

Hee Kyung Kim

Peptron Inc., Yuseong-gu, Daejeon, Republic of Korea

Ho-Il Choi

Peptron Inc., Yuseong-gu, Daejeon, Republic of Korea

Barry J. Hoffer

Department of Neurosurgery, Case Western Reserve University School of Medicine, Cleveland, OH, USA

Chaim G. Pick

Department of Anatomy and Anthropology, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv 69978, Israel; Sagol School of Neuroscience, Tel-Aviv University, Tel-Aviv 69978, Israel; Center for the Biology of Addictive Diseases, Tel-Aviv University, Tel-Aviv 69978, Israel

Nigel H. Greig

Drug Design and Development Section, Translational Gerontology Branch, Intramural Research Program, National Institutes of Health, National Institute on Aging, Baltimore, MD, USA; Corresponding author.

Dong Seok Kim

Drug Design and Development Section, Translational Gerontology Branch, Intramural Research Program, National Institutes of Health, National Institute on Aging, Baltimore, MD, USA; Department of Neuroscience, Karolinska Institute, Stockholm, Sweden